AU2564100A - Pluripotential cells-1 - Google Patents

Pluripotential cells-1 Download PDF

Info

Publication number
AU2564100A
AU2564100A AU25641/00A AU2564100A AU2564100A AU 2564100 A AU2564100 A AU 2564100A AU 25641/00 A AU25641/00 A AU 25641/00A AU 2564100 A AU2564100 A AU 2564100A AU 2564100 A AU2564100 A AU 2564100A
Authority
AU
Australia
Prior art keywords
cell
cells
human
culture
pluripotential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25641/00A
Other languages
English (en)
Inventor
Peter Andrews
Paul Kemp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercytex Ltd
Original Assignee
Intercytex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercytex Ltd filed Critical Intercytex Ltd
Publication of AU2564100A publication Critical patent/AU2564100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU25641/00A 1999-02-20 2000-02-18 Pluripotential cells-1 Abandoned AU2564100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9903805.1A GB9903805D0 (en) 1999-02-20 1999-02-20 Pluripotential cells-1
GB9903805 1999-02-20
PCT/GB2000/000582 WO2000049138A2 (fr) 1999-02-20 2000-02-18 Cellules 1 multipotentes

Publications (1)

Publication Number Publication Date
AU2564100A true AU2564100A (en) 2000-09-04

Family

ID=10848085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25641/00A Abandoned AU2564100A (en) 1999-02-20 2000-02-18 Pluripotential cells-1

Country Status (7)

Country Link
EP (1) EP1155118A2 (fr)
JP (1) JP2002536976A (fr)
AU (1) AU2564100A (fr)
CA (1) CA2371895A1 (fr)
GB (1) GB9903805D0 (fr)
HK (1) HK1040532A1 (fr)
WO (1) WO2000049138A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118984D0 (en) * 2001-08-03 2001-09-26 Intercytex Ltd Fusion of cells
US20030113910A1 (en) * 2001-12-18 2003-06-19 Mike Levanduski Pluripotent stem cells derived without the use of embryos or fetal tissue
WO2004044188A1 (fr) 2002-11-14 2004-05-27 Intercytex Limited Culture de cellules favorisant la pousse des cheveux
WO2007026255A2 (fr) * 2005-06-22 2007-03-08 Universitetet I Oslo Cellules dedifferenciees et procedes permettant de realiser et d'utiliser des cellules dedifferenciees
US7922688B2 (en) 2007-01-08 2011-04-12 Restoration Robotics, Inc. Automated delivery of a therapeutic or cosmetic substance to cutaneous, subcutaneous and intramuscular tissue regions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation

Also Published As

Publication number Publication date
WO2000049138A2 (fr) 2000-08-24
EP1155118A2 (fr) 2001-11-21
WO2000049138A3 (fr) 2001-02-22
JP2002536976A (ja) 2002-11-05
CA2371895A1 (fr) 2000-08-24
HK1040532A1 (zh) 2002-06-14
GB9903805D0 (en) 1999-04-14

Similar Documents

Publication Publication Date Title
US20190225937A1 (en) Bank of stem cells for producing cells for transplantation having hla antigens matching those of transplant recipients and methods for making and using such a stem cell bank
Hipp et al. Sources of stem cells for regenerative medicine
Oback et al. Donor cells for nuclear cloning: many are called, but few are chosen
US8273571B2 (en) Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
US20040120932A1 (en) In vitro-derived adult pluripotent stem cells and uses therefor
Lewandowski et al. Techniques of human embryonic stem cell and induced pluripotent stem cell derivation
KR101538089B1 (ko) 배아줄기세포-유사 세포
Flasza et al. Reprogramming in inter-species embryonal carcinoma–somatic cell hybrids induces expression of pluripotency and differentiation markers
Do et al. Reprogramming somatic gene activity by fusion with pluripotent cells
de Sousa Lopes et al. On the formation of germ cells: the good, the bad and the ugly
Ma Biomaterials and regenerative medicine
US20100233142A1 (en) Stem Cells Derived from Uniparental Embryos and Methods of Use Thereof
Muzaffar et al. Equivalency of buffalo (Bubalus bubalis) embryonic stem cells derived from fertilized, parthenogenetic, and hand-made cloned embryos
EP1513928B1 (fr) Banque de cellules souches destinees a la production de cellules pour transplantation possedant des antigenes hla correspondant a ceux des receveurs de transplant, et procedes de constitution et d'utilisation d'une telle banque de cellules souches
EP1153123A2 (fr) Cellules-2 pluripotentes
AU2564100A (en) Pluripotential cells-1
Serov et al. Reprogramming mediated by cell fusion technology
Tada Nuclear reprogramming: an overview
Nehlin et al. Strategies for future histocompatible stem cell therapy
JP2023090959A (ja) 幹細胞の製造方法、及び癌細胞化のリスク低減方法
Du et al. Developmental incompatibility of human parthenogenetic embryonic stem cells in mouse blastocysts
Maruotti et al. Faithful reprograming to pluripotency in mammals—What does nuclear transfer teach us?
Tada Nuclear Reprogramming
Lim et al. Fetal Cell Reprogramming and Transformation
Goh Using mouse embryonic fibroblast (MEF) as feeder cells for production of embryonic stem cell (ESC) line in the murine and caprine/Goh Siew Ying